Search results for " biotherapeutics" in Articles / App Notes
								 					Article
				
				Digitalization: The Route to Biopharma 4.0
								
	Industry 4.0, also known as the Fourth Industrial Revolution (4IR), will result in the digital transformation of the manufacturing sector. It is propelled by transformative trends such as the prolif…								
								 					Article
				
				Determining and Optimizing Dynamic Binding Capacity
								
	
	
	
Dynamic binding capacity (DBC) indicates the quantity of a specific biomolecule that can be bound during a chromatography purification step under a specific set of process conditions. Determ…								
								 					Article
				
				eBook: Purification of Antibody Therapeutics - Approach for Diversified Pipeline
								
	
	
	Antibody therapeutics are the largest class of biotherapeutics. Over the years, development beyond traditional monoclonal antibodies (mAbs) has increased. Today, we see multispecific and bispe…								
								 					Article
				
				Expanding the Emerging Therapeutic Horizon
								
	
	
	Despite the successes that have already been achieved with emerging therapy development and manufacturing, companies are still facing numerous challenges. Aspects such as demand for accelerate…								
								 					Article
				
				Report from the 12th Plasma Product Biotechnology Forum
								When questioned on what other areas relevant to plasma biotherapeutics they would like to see, some responses given were: 
	
	
		
		· 
		
		Sustainability 
		
		
		· 
		
		Artificial Intelligence (AI)…								
								 					Article
				
				PEPTalk Event
								
	  
	
	
	
	Visit us at the PepTalk conference in San Diego. Attend our talk, powerpoint presentations, and panel discussions to learn the latest in protein science. 
	
	
	
	  
	LEARN MORE >> …								
								 					Article
				
				Capture of Bispecific Antibodies and Removal of Product-Related Impurities
								
	
	
	
	The biotherapeutics pipeline is becoming increasingly diverse as antibody variants such as bispecifics, conjugates, and fragments move through preclinical stages to commercial manufacturin…								
								 					Article
				
				Get to know: mAb variants - eLearning
								
	
	
	The diversity of antibody variants in the biotherapeutics pipeline are increasing with a growing interest for molecules like antibody fragments and bispecific antibodies (bsAbs). Cytiva has pu…								
								 					Article
				
				Late stage failures of monoclonal antibodies
								
	
	
	
	
	Despite the significant developments that have happened in clinical trial design and the considerable experience that the biopharma industry has gained in the past three decades, therapeutic…								
								 					Article
				
				Principles of Cell Line Development
								
	 
	
	  
	
	This free online course provides an overview of how cell line development plays a critical role in a biotherapeutic drug’s path to market. It also takes a closer look at where it fits int…